#	Pagina
attuale pagina	/open-h2020/projects/193285/index.html

Opendata, web and dolomites

PoC-ID

Platform for ultra-sensitive Point-of-Care diagnostics for Infectious Diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Outcomes and
results

PoC-ID project word cloud

Explore the words cloud of the PoC-ID project. It provides you a very rough idea of what is the project "PoC-ID" about.

flows expertise faster sensitive spread healthcare combination electronics microelectronics interdisciplinary reduce nanomembrane detection causes variety medicine capture sensitivity death health treatment interaction diagnostics microfluidics diagnostic innovative world usability biosensing selectivity diseases miniaturised prevention volumes context sensing clinical rapid types care robustness purposes point ultra respiratory virus designing disease sensors platform breakthrough therapeutic pathogens molecular speed syncytial prototype performance micro arising pathogen diagnosis nanoelectronic read environmental food members accurate patient engineered paediatric thanks disposable data realised demand virtually liquid standard quality integration poc life molecules host infections personalised id morbidity easily monitoring combine infectious vitro reached

Project "PoC-ID" data sheet

The following table provides information about the project.

Coordinator	TECHNISCHE UNIVERSITAT BERLIN Organization address address: STRASSE DES 17 JUNI 135 city: BERLIN postcode: 10623 website: www.tu-berlin.de contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Germany [DE]
Project website	http://www.poc-id.eu/
Total cost	5˙963˙133 €
EC max contribution	5˙963˙132 € (100%)
Programme	1. H2020-EU.3.1.3. (Treating and managing disease)
Code Call	H2020-PHC-2014-two-stage
Funding Scheme	RIA
Starting year	2015
Duration (year-month-day)	from 2015-05-01 to 2018-11-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	TECHNISCHE UNIVERSITAT BERLIN TECHNISCHE UNIVERSITAT BERLIN Organization address address: STRASSE DES 17 JUNI 135 city: BERLIN postcode: 10623 website: www.tu-berlin.de contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (BERLIN)	coordinator	1˙315˙125.00
2	FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. Organization address address: HANSASTRASSE 27C city: MUNCHEN postcode: 80686 website: www.fraunhofer.de contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (MUNCHEN)	participant	829˙803.00
3	STICHTING KATHOLIEKE UNIVERSITEIT STICHTING KATHOLIEKE UNIVERSITEIT Organization address address: GEERT GROOTEPLEIN NOORD 9 city: NIJMEGEN postcode: 6525 EZ website: www.radboudumc.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (NIJMEGEN)	participant	693˙432.00
4	FRIEDRICH-SCHILLER-UNIVERSITAT JENA FRIEDRICH-SCHILLER-UNIVERSITAT JENA Organization address address: FURSTENGRABEN 1 city: JENA postcode: 7743 website: www.uni-jena.de contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (JENA)	participant	666˙906.00
5	APTARION BIOTECH AG APTARION BIOTECH AG Organization address address: MAX DOHRN STR 8-10 city: BERLIN postcode: 10589 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (BERLIN)	participant	434˙945.00
6	CNM TECHNOLOGIES GMBH CNM TECHNOLOGIES GMBH Organization address address: MORGENBREEDE 1 city: BIELEFELD postcode: 33615 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (BIELEFELD)	participant	397˙897.00
7	NOXXON PHARMA AG NOXXON PHARMA AG Organization address address: MAX DOHRN STRASSE 8 10 city: BERLIN postcode: 10589 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (BERLIN)	participant	387˙926.00
8	SIGNALGENERIX LIMITED SIGNALGENERIX LIMITED Organization address address: GRIGORI AFXENTIOU 23C MESA GEITONIA city: LIMASSOL postcode: 4003 website: www.signalgenerix.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	CY (LIMASSOL)	participant	323˙000.00
9	enablingMNT GMBH enablingMNT GMBH Organization address address: HOLSTEINISCHE STR 23 city: BERLIN postcode: 12161 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (BERLIN)	participant	320˙753.00
10	SERVIZO GALEGO DE SAUDE SERVIZO GALEGO DE SAUDE Organization address address: Edificio Administrativo San Lázaro city: Santiago de Compostela postcode: 15703 website: www.sergas.es contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (Santiago de Compostela)	participant	214˙606.00
11	MICROPATHOLOGY LIMITED MICROPATHOLOGY LIMITED Organization address address: SIR WILLIAM LYONS ROAD city: COVENTRY postcode: CV4 7EZ website: www.micropathology.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (COVENTRY)	participant	118˙625.00
12	MERCENE LABS AB MERCENE LABS AB Organization address address: TEKNIKRINGEN 38 city: STOCKHOLM postcode: 114 28 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	SE (STOCKHOLM)	participant	115˙000.00
13	VAN HEEREN ARIE HENDRIK VAN HEEREN ARIE HENDRIK Organization address address: DRAKENSTEYNLAAN 34 city: DORDRECHT postcode: 3319 RG website: www.enablingMNT.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (DORDRECHT)	participant	81˙112.00
14	MEMSOP CONSULTING MEMSOP CONSULTING Organization address address: SAT VIDRA city: VIDRA VRANCEA postcode: 627415 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	RO (VIDRA VRANCEA)	participant	64˙000.00

Map

Project objective

The aim of the PoC-ID project is to develop new micro- and nanoelectronic-based sensing and integration concepts for advanced miniaturised in vitro diagnostic devices. The project addresses the increasing demand for rapid and ultra-sensitive point-of-care diagnostics to reduce healthcare costs and increase the quality of life with a focus on infectious diseases, one of the world’s leading causes of morbidity and death. Interdisciplinary collaboration using the technology and expertise of the consortium members will be applied to develop and test a breakthrough PoC prototype for the diagnosis of respiratory syncytial virus infections and host responses in the paediatric context. PoC-ID will enable new types of point-of-care diagnostics for virtually any type of complex liquid sample. Applications are disease diagnosis, monitoring of therapeutic responses, clinical research of pathogen-host interaction and personalised medicine. The platform technology can easily be adapted to a variety of diagnostic or biosensing purposes, such as in health/environmental monitoring or food quality testing. PoC-ID will combine the detection of both pathogens and host responses leading to more accurate diagnosis as compared to the current standard which is focused on detection of pathogens only. This novel approach will support prevention and control of pathogen spread and enable faster and more personalised patient treatment. Improved performance in terms of robustness, sensitivity and selectivity will be reached by a combination of innovative nanomembrane technology, molecular engineered capture molecules and two novel sensing concepts. Further advances will be realised in terms of usability and speed of data-analysis arising from the integration of sensors, read-out electronics and microfluidics into one user friendly point-of-care (PoC) platform. Costs of the new disposable sensors will be ultra-low at high volumes, thanks to designing into microelectronics production flows.

Deliverables

List of deliverables.
Detailed dissemination and communication plan	Documents, reports	2020-03-20 09:24:43

Take a look to the deliverables list in detail: detailed list of PoC-ID deliverables.

Publications

List of publications.
year	authors and title	journal	last update
2018	Patrick Reinecke, Marie-Theres Putze, Leopold Georgi, Ruben Kahle, David Kaiser, Daniel HÃ¼ger, Pavel Livshits, Jens WeidenmÃ¼ller, Thomas Weimann, Andrey Turchanin, Tanja Braun, Karl-Friedrich Becker, Martin Schneider-Ramelow, Klaus-Dieter Lang Scalable hybrid microelectronic-microfluidic integration of highly sensitive biosensors published pages: 000672-000679, ISSN: 2380-4505, DOI: 10.4071/2380-4505-2018.1.000672	International Symposium on Microelectronics 2018/1	2020-03-20
2017	Pavel Livshits, Andreas Jupe, Stefan Kahnert, Martin Figge, Stefan Mross, Michael Goertz, Holger Vogt, Andreas Goehlich Poster session 10: Medical measuring techniques I published pages: , ISSN: 0013-5585, DOI: 10.1515/bmt-2017-5031	Biomedical Engineering / Biomedizinische Technik 62/s1	2020-03-20

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "POC-ID" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "POC-ID" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More

SHIGETECVAX (2019)

Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea

Read More